Granulomatous diseases are highly destructive tissue reactions which often involve the lung. Clinically, pulmonary granulomatous inflammation is difficult to manage, requiring potent anti-inflammatory drugs that can compromise the patient's metabolic and immunologic integrity. Clearly, understanding the basic immunoregulatory mechanisms operative in the initiation, maintenance and resolution of these inflammatory processes may afford better approaches for treatment of these diseases. While most studies have examined the function of granuloma macrophages, few studies have investigated the role of lymphocytes, particularly natural killer (NK) lymphocytes, in the initiation, maintenance and resolution of granulomatous inflamation. This proposal will focus on the immunoregulatory effects that subsets of NK lynphocytes have on the various stages of granuloma development. This study will specifically focus on: 1) The isolation and characterization of lymphocyte subsets (particularly natural killer cells) obtained from hypersensitivity lung granulomas induced by embolization of Schistosome mansoni eggs. This study will involve extensive flow cytometric surface marker analysis and functional NK assays; 2) An examination of the immunoregulatory effects of NK cells on the development of S. mansoni egg induced lung granulomas. This will involve a) in vivo depletion of NK cells by administration of cytotoxic antibodies reactive with NK specific surface markers; b) Adoptive transfer of cells selectively enriched for or depleted of NK cells; c) Adoptive transfer of NK cells positively selected by fluorescent activated cell sorting; and d) Adoptive transfer of cells from mice genetically NK deficient (beige) or mature T cell deficient (nude). Assessment of the effects of these treatments will be determined by morphometric analysis of lung granulomas 4, 8, 16 and 32 days after embolization of S. mansoni eggs and complete surface marker analysis and NK function of lymphocyte subpopulation within the spleens and lungs of responding animals. The effects of NK cells on soluble schistosome egg antigen (SEA) induced B cell immunoglobulin production or lymphokine production (migration inhibitory factor (MIF) and interleukin-2 (IL-2) will be determined using in vitro systems. Finally, we will analyze the dynamic interplay between NK cells and granuloma derived macrophages (taken at various stages of granuloma development) by determining how macrophage derived cytokines (IL-1) and arachidonic acid metabolites effect NK function.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Unknown (R23)
Project #
7R23HL037638-01
Application #
3449449
Study Section
Pathology A Study Section (PTHA)
Project Start
1986-06-01
Project End
1989-05-31
Budget Start
1986-06-01
Budget End
1987-05-31
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Overall Medical
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Wright, D T; Adler, K B; Akley, N J et al. (1994) Ozone stimulates release of platelet activating factor and activates phospholipases in guinea pig tracheal epithelial cells in primary culture. Toxicol Appl Pharmacol 127:27-36
Schwarz, R E; Vujanovic, N L; Hiserodt, J C (1989) Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res 49:1441-6
Sarneva, M; Vujanovic, N L; Van den Brink, M R et al. (1989) Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells. Cell Immunol 118:448-57
Vujanovic, N L; Herberman, R B; Olszowy, M W et al. (1988) Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells. Cancer Res 48:884-90
Maghazachi, A A; Vujanovic, N L; Herberman, R B et al. (1988) Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells. J Immunol 140:2846-52
Long, G S; Hiserodt, J C; Harnaha, J B et al. (1988) Lymphokine-activated killer cell purging of leukemia cells from bone marrow prior to syngeneic transplantation. Transplantation 46:433-8
Vujanovic, N L; Herberman, R B; Hiserodt, J C (1988) Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity. Cancer Res 48:878-83
Vujanovic, N L; Herberman, R B; Maghazachi, A A et al. (1988) Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells. J Exp Med 167:15-29
Remick, D G; Kunkel, S L; Higashi, G I et al. (1988) Suppression of natural killer cytolytic activity in mice undergoing pulmonary granulomatous inflammation. J Immunol 140:2225-30
Schwarz, R E; Hiserodt, J C (1988) The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes. J Immunol 141:3318-23